| Segment Disclosures |
Segment Disclosures
The Company evaluates its business and allocates resources based on its reportable business segments: (i) senior housing triple-net, (ii) SHOP, (iii) life science, and (iv) medical office. The Company has non-reportable segments that are comprised primarily of the Company’s unconsolidated joint ventures, hospital properties, and debt investments. The accounting policies of the segments are the same as those described under Summary of Significant Accounting Policies (see Note 2). During the first quarter of 2019, as a result of a change in how operating results are reported to the chief operating decision makers for the purpose of evaluating performance and allocating resources, the Company reclassified operating results related to two facilities from its other non-reportable segment to its medical office segment. Accordingly, all prior period segment information has been recast to conform to current period presentation. During the years ended December 31, 2019, 2018, and 2017, 41, 22, and 25 senior housing triple-net facilities, respectively, were transferred to the Company’s SHOP segment as a result of terminating the triple-net leases and transitioning the assets to a RIDEA structure. When an asset is transferred from one segment to another, the results associated with that asset are included in the original segment until the date of transfer. Results generated after the transfer date are included in the new segment. The Company evaluates performance based on: property NOI and Adjusted NOI. NOI is defined as real estate revenues (inclusive of rental and related revenues, resident fees and services, and income from direct financing leases), less property level operating expenses (which exclude transition costs); NOI excludes all other financial statement amounts included in net income (loss). Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles, termination fees, actuarial reserves for insurance claims that have been incurred but not reported, and the impact of deferred community fee income and expense. NOI and Adjusted NOI exclude the Company's share of income (loss) from unconsolidated joint ventures, which is recognized as equity income (loss) from unconsolidated joint ventures in the consolidated statements of operations. Non-segment assets consist of assets in the Company's other non-reportable segments and corporate non-segment assets. Corporate non-segment assets consist primarily of corporate assets, including cash and cash equivalents, restricted cash, accounts receivable, net, marketable equity securities, and real estate assets and liabilities held for sale. See Note 19 for other information regarding concentrations of credit risk. The following tables summarize information for the reportable segments (in thousands): For the year ended December 31, 2019: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Senior Housing Triple-Net | | SHOP | | Life Science | | Medical Office | | Other Non-reportable | | Corporate Non-segment | | Total | Real estate revenues(1) | | $ | 199,441 |
| | $ | 725,171 |
| | $ | 440,784 |
| | $ | 571,530 |
| | $ | 50,613 |
| | $ | — |
| | $ | 1,987,539 |
| Operating expenses | | (4,565 | ) | | (565,713 | ) | | (107,472 | ) | | (201,538 | ) | | (82 | ) | | — |
| | (879,370 | ) | NOI | | 194,876 |
| | 159,458 |
| | 333,312 |
| | 369,992 |
| | 50,531 |
| | — |
| | 1,108,169 |
| Adjustments to NOI(2) | | 2,725 |
| | 2,872 |
| | (22,120 | ) | | (5,877 | ) | | 1,342 |
| | — |
| | (21,058 | ) | Adjusted NOI | | 197,601 |
| | 162,330 |
| | 311,192 |
| | 364,115 |
| | 51,873 |
| | — |
| | 1,087,111 |
| Addback adjustments | | (2,725 | ) | | (2,872 | ) | | 22,120 |
| | 5,877 |
| | (1,342 | ) | | — |
| | 21,058 |
| Interest income | | — |
| | — |
| | — |
| | — |
| | 9,844 |
| | — |
| | 9,844 |
| Interest expense | | (1,003 | ) | | (7,519 | ) | | (277 | ) | | (434 | ) | | — |
| | (216,386 | ) | | (225,619 | ) | Depreciation and amortization | | (55,361 | ) | | (214,590 | ) | | (168,339 | ) | | (214,669 | ) | | (7,030 | ) | | — |
| | (659,989 | ) | General and administrative | | — |
| | — |
| | — |
| | — |
| | — |
| | (92,966 | ) | | (92,966 | ) | Transaction costs | | — |
| | — |
| | — |
| | — |
| | — |
| | (8,743 | ) | | (8,743 | ) | Recoveries (impairments), net | | (43,859 | ) | | (164,369 | ) | | — |
| | (17,332 | ) | | (377 | ) | | — |
| | (225,937 | ) | Gain (loss) on sales of real estate, net | | 3,557 |
| | 19,384 |
| | 3,651 |
| | 3,139 |
| | (6,831 | ) | | — |
| | 22,900 |
| Loss on debt extinguishment | | — |
| | — |
| | — |
| | — |
| | — |
| | (58,364 | ) | | (58,364 | ) | Other income (expense), net | | — |
| | 160,886 |
| | — |
| | — |
| | 8,137 |
| | 13,106 |
| | 182,129 |
| Income tax benefit (expense) | | — |
| | — |
| | — |
| | — |
| | — |
| | 17,262 |
| | 17,262 |
| Equity income (loss) from unconsolidated joint ventures | | — |
| | — |
| | — |
| | — |
| | (8,625 | ) | | — |
| | (8,625 | ) | Net income (loss) | | $ | 98,210 |
| | $ | (46,750 | ) | | $ | 168,347 |
| | $ | 140,696 |
| | $ | 45,649 |
| | $ | (346,091 | ) | | $ | 60,061 |
|
_______________________________________ | | (1) | Represents rental and related revenues, resident fees and services, and income from DFLs. |
| | (2) | Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims that have been incurred but not reported, deferral of community fees, net, and termination fees. |
For the year ended December 31, 2018: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Senior Housing Triple-Net | | SHOP | | Life Science | | Medical Office | | Other Non-reportable | | Corporate Non-segment | | Total | Real estate revenues(1) | | $ | 276,091 |
| | $ | 547,976 |
| | $ | 395,064 |
| | $ | 547,375 |
| | $ | 69,777 |
| | $ | — |
| | $ | 1,836,283 |
| Operating expenses | | (3,618 | ) | | (414,312 | ) | | (91,742 | ) | | (195,100 | ) | | (266 | ) | | — |
| | (705,038 | ) | NOI | | 272,473 |
| | 133,664 |
| | 303,322 |
| | 352,275 |
| | 69,511 |
| | — |
| | 1,131,245 |
| Adjustments to NOI(2) | | 2,127 |
| | 2,875 |
| | (9,589 | ) | | (6,690 | ) | | (627 | ) | | — |
| | (11,904 | ) | Adjusted NOI | | 274,600 |
| | 136,539 |
| | 293,733 |
| | 345,585 |
| | 68,884 |
| | — |
| | 1,119,341 |
| Addback adjustments | | (2,127 | ) | | (2,875 | ) | | 9,589 |
| | 6,690 |
| | 627 |
| | — |
| | 11,904 |
| Interest income | | — |
| | — |
| | — |
| | — |
| | 10,406 |
| | — |
| | 10,406 |
| Interest expense | | (2,404 | ) | | (2,725 | ) | | (316 | ) | | (474 | ) | | (1,469 | ) | | (258,955 | ) | | (266,343 | ) | Depreciation and amortization | | (79,605 | ) | | (104,405 | ) | | (140,480 | ) | | (200,430 | ) | | (24,579 | ) | | — |
| | (549,499 | ) | General and administrative | | — |
| | — |
| | — |
| | — |
| | — |
| | (96,702 | ) | | (96,702 | ) | Transaction costs | | — |
| | — |
| | — |
| | — |
| | — |
| | (10,772 | ) | | (10,772 | ) | Recoveries (impairments), net | | — |
| | (44,343 | ) | | (7,639 | ) | | — |
| | (3,278 | ) | | — |
| | (55,260 | ) | Gain (loss) on sales of real estate, net | | 641 |
| | 93,977 |
| | 806,184 |
| | 4,428 |
| | 20,755 |
| | — |
| | 925,985 |
| Loss on debt extinguishment | | — |
| | — |
| | — |
| | — |
| | — |
| | (44,162 | ) | | (44,162 | ) | Other income (expense), net | | — |
| | — |
| | — |
| | — |
| | 9,605 |
| | 3,711 |
| | 13,316 |
| Income tax benefit (expense) | | — |
| | — |
| | — |
| | — |
| | — |
| | 17,854 |
| | 17,854 |
| Equity income (loss) from unconsolidated joint ventures | | — |
| | — |
| | — |
| | — |
| | (2,594 | ) | | — |
| | (2,594 | ) | Net income (loss) | | $ | 191,105 |
| | $ | 76,168 |
| | $ | 961,071 |
| | $ | 155,799 |
| | $ | 78,357 |
| | $ | (389,026 | ) | | $ | 1,073,474 |
|
_______________________________________ | | (1) | Represents rental and related revenues, resident fees and services, and income from DFLs. |
| | (2) | Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims that have been incurred but not reported, deferral of community fees, net, and termination fees. |
For the year ended December 31, 2017: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Senior Housing Triple-Net | | SHOP | | Life Science | | Medical Office | | Other Non-reportable | | Corporate Non-segment | | Total | Real estate revenues(1) | | $ | 313,547 |
| | $ | 525,473 |
| | $ | 358,816 |
| | $ | 512,385 |
| | $ | 81,920 |
| | $ | — |
| | $ | 1,792,141 |
| Operating expenses | | (3,819 | ) | | (396,491 | ) | | (78,001 | ) | | (187,688 | ) | | (252 | ) | | — |
| | (666,251 | ) | NOI | | 309,728 |
| | 128,982 |
| | 280,815 |
| | 324,697 |
| | 81,668 |
| | — |
| | 1,125,890 |
| Adjustments to NOI(2) | | 17,098 |
| | 33,227 |
| | (4,517 | ) | | (5,405 | ) | | (1,993 | ) | | — |
| | 38,410 |
| Adjusted NOI | | 326,826 |
| | 162,209 |
| | 276,298 |
| | 319,292 |
| | 79,675 |
| | — |
| | 1,164,300 |
| Addback adjustments | | (17,098 | ) | | (33,227 | ) | | 4,517 |
| | 5,405 |
| | 1,993 |
| | — |
| | (38,410 | ) | Interest income | | — |
| | — |
| | — |
| | — |
| | 56,237 |
| | — |
| | 56,237 |
| Interest expense | | (2,518 | ) | | (7,920 | ) | | (373 | ) | | (506 | ) | | (4,230 | ) | | (292,169 | ) | | (307,716 | ) | Depreciation and amortization | | (103,820 | ) | | (103,162 | ) | | (128,864 | ) | | (176,507 | ) | | (22,373 | ) | | — |
| | (534,726 | ) | General and administrative | | — |
| | — |
| | — |
| | — |
| | — |
| | (88,772 | ) | | (88,772 | ) | Transaction costs | | — |
| | — |
| | — |
| | — |
| | — |
| | (7,963 | ) | | (7,963 | ) | Recoveries (impairments), net | | (22,590 | ) | | — |
| | — |
| | — |
| | (143,794 | ) | | — |
| | (166,384 | ) | Gain (loss) on sales of real estate, net | | 280,349 |
| | 17,485 |
| | 45,916 |
| | 9,095 |
| | 3,796 |
| | — |
| | 356,641 |
| Loss on debt extinguishment | | — |
| | — |
| | — |
| | — |
| | — |
| | (54,227 | ) | | (54,227 | ) | Other income (expense), net | | — |
| | — |
| | — |
| | — |
| | 50,895 |
| | (19,475 | ) | | 31,420 |
| Income tax benefit (expense) | | — |
| | — |
| | — |
| | — |
| | — |
| | 1,333 |
| | 1,333 |
| Equity income (loss) from unconsolidated joint ventures | | — |
| | — |
| | — |
| | — |
| | 10,901 |
| | — |
| | 10,901 |
| Discontinued operations | | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| Net income (loss) | | $ | 461,149 |
| | $ | 35,385 |
| | $ | 197,494 |
| | $ | 156,779 |
| | $ | 33,100 |
| | $ | (461,273 | ) | | $ | 422,634 |
|
_______________________________________ | | (1) | Represents rental and related revenues, resident fees and services, and income from DFLs. |
| | (2) | Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, actuarial reserves for insurance claims that have been incurred but not reported, deferral of community fees, net, and termination fees. |
The following table summarizes the Company’s revenues by segment (in thousands): | | | | | | | | | | | | | | | | Year Ended | | | December 31, | Segments | | 2019 | | 2018 | | 2017 | Senior housing triple-net | | $ | 199,441 |
| | $ | 276,091 |
| | $ | 313,547 |
| SHOP | | 725,171 |
| | 547,976 |
| | 525,473 |
| Life science | | 440,784 |
| | 395,064 |
| | 358,816 |
| Medical office | | 571,530 |
| | 547,375 |
| | 512,385 |
| Other non-reportable segments | | 60,457 |
| | 80,183 |
| | 138,157 |
| Total revenues | | $ | 1,997,383 |
| | $ | 1,846,689 |
| | $ | 1,848,378 |
|
The following table summarizes the Company’s total assets by segment (in thousands): | | | | | | | | | | | | December 31, | Segment | | 2019 | | 2018 | Senior housing triple-net | | $ | 1,012,443 |
| | $ | 2,965,679 |
| SHOP | | 2,969,871 |
| | 2,173,795 |
| Life science | | 5,688,659 |
| | 4,303,471 |
| Medical office | | 4,761,357 |
| | 4,603,794 |
| Reportable segment assets | | 14,432,330 |
| | 14,046,739 |
| Accumulated depreciation and amortization | | (2,966,987 | ) | | (2,997,012 | ) | Net reportable segment assets | | 11,465,343 |
| | 11,049,727 |
| Other non-reportable segment assets | | 1,233,752 |
| | 847,921 |
| Assets held for sale, net | | 504,394 |
| | 108,086 |
| Other non-segment assets | | 829,402 |
| | 712,819 |
| Total assets | | $ | 14,032,891 |
| | $ | 12,718,553 |
|
See Notes 3 and 4 for significant transactions impacting the Company's segment assets during the periods presented. The Company completed the required annual goodwill impairment test during the fourth quarter of 2019, 2018, and 2017, and no impairment was recognized. At December 31, 2019 goodwill of $47 million was allocated to segment assets as follows: (i) senior housing triple-net—$14 million, (ii) SHOP—$16 million, (iii) medical office—$13 million, and (iv) other—$4 million. At December 31, 2018 goodwill of $47 million was allocated to segment assets as follows: (i) senior housing triple-net—$21 million, (ii) SHOP—$9 million, (iii) medical office—$11 million, and (iv) other—$6 million. During the year ended December 31, 2019, as a result of transferring 41 senior housing triple-net facilities to the Company’s SHOP segment and two facilities from its other non-reportable segments to its medical office segment, the Company reallocated $7 million of goodwill from the senior housing triple-net segment to the SHOP segment and $2 million of goodwill from other non-reportable segments to the MOB segment.
|